Evidence map›Paper›PMID 42505642›Full record

ArticleAntibiotics (Basel, Switzerland)2026

Multicenter Point-Prevalence Study of Carbapenem-Resistant

Esra Erdem Kıvrak, Deniz Özer, Sinan Mermer, Ahmet Sertçelik, Hasip Kahraman, Müge Toygar Deniz, Damla Ertürk, Arzu Nazlı, Hüseyin Aytaç Erdem, Ongun Yeniçeri and 1 more

Abstract read
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Esra Erdem KıvrakDepartment of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Manisa Celal Bayar University, Manisa 45140, Türkiye.ORCID 0000-0003-3192-724X
Deniz ÖzerDepartment of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Manisa Celal Bayar University, Manisa 45140, Türkiye.
Sinan MermerDepartment of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, İzmir University of Economics Medical Point Hospital, İzmir 35100, Türkiye.
Ahmet SertçelikDepartment of Infectious Diseases and Clinical Microbiology, Division of Epidemiology, Faculty of Medicine, Ankara Yıldırım Beyazıt University, Ankara Bilkent City Hospital, Ankara 06800, Türkiye.ORCID 0000-0003-4301-0586
Hasip KahramanDepartment of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Eskişehir Osmangazi University, Eskişehir 26480, Türkiye.ORCID 0000-0002-5120-4877
Müge Toygar DenizDepartment of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Kocaeli University, Kocaeli 41380, Türkiye.ORCID 0000-0002-6946-2727
Damla ErtürkDepartment of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Çukurova University, Adana 01330, Türkiye.ORCID 0000-0002-2163-5844
Arzu NazlıDepartment of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Dokuz Eylül University, İzmir 35100, Türkiye.
Hüseyin Aytaç ErdemDepartment of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Ege University, İzmir 35100, Türkiye.
Ongun YeniçeriDepartment of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Çukurova University, Adana 01330, Türkiye.ORCID 0009-0009-6927-7052
Meltem TaşbakanDepartment of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Ege University, İzmir 35100, Türkiye.ORCID 0000-0002-4689-720X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCarbapenem-resistant MATERIALS AND

methodsThis multicenter cross-sectional point-prevalence study was conducted in seven tertiary-care hospitals located in different regions of Türkiye. On 19 February 2026, all hospitalized adult patients and microbiological cultures obtained on the study day were evaluated. Demographic, clinical, microbiological, antimicrobial treatment, infection control, and hospital-level data were collected using a standardized case report form. Culture-based prevalence estimates were calculated with 95% confidence intervals (CIs).

resultsA total of 26 patients with carbapenem-resistant

conclusionsCarbapenem-resistant

Indexed as

antimicrobial resistancecarbapenem resistancehealthcare-associated infectioninfection controlKlebsiella spp.point prevalence

Identifiers

PMID42505642
PMCPMC13403536

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.